Double-Stenting of the Left Main Coronary Artery lesions : Safety , Clinical Outcome and Long Term Follow-up

C l i n M e d International Library Citation: Ng W, Lundstrom R (2015) Double-Stenting of the Left Main Coronary Artery lesions: Safety, Clinical Outcome and Long Term Follow-up. Int J Clin Cardiol 2:022 Received: January 28, 2015: Accepted: February 27, 2015: Published: February 28, 2015 Copyright: © 2015 Ng W. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Ng and Lundstrom. Int J Clin Cardiol 2015, 2:1 ISSN: 2378-2951


Introduction
With current clinical environment, percutaneous coronary intervention (PCI) on protected or unprotected left main coronary artery (LMCA) using bare metal stent (BMS) or more frequently drug eluting stent (DES) are not uncommon practice [1][2][3][4][5][6].However, stenting to LMCA is still challenging, partly related to the possible hemodynamic instability during stent deployment with transient occlusion of LMCA, more importantly, there exists limited success of the first stent has a mean of 18 atmospheres (atm) (range 12-24, mode of 20 atm), whereas that of the second stent at mean of 15.4 atmospheres (range 12-20, mode of 14 atm).As described by most operators, after deployment of the first stent at high pressure, there existed suboptimal angiographic result leading to placement of the second stent.In some scenarios, the operators decided to use a drug eluting stent, oftenly, a smaller stent-size available in market at that period, with the aim to deploy a second larger bare metal stent to improve the angiographic result, hoping that there still exists some treatment effect from the use of coated stent.
The choice of stenting strategy, type of drug eluting stent (DES) or bare metal stent (BMS) used, use of intravascular ultrasound (IVUS), balloon inflation pressure and the decision to perform final kissing balloon inflations were left to the discretion of the individual operator.The use of IVUS to guide stenting procedure is uncommon, and occurred in four patients only.In addition, there existed no standard classification/definition of plaque prolapsed as described by the operators, the decisions to use the second stent was per operator discretion.All patents were treated for at least 12 months with dual antiplatelet therapy following PCI.Beyond 12 months, decision to continue clopidogrel therapy or not was left to the operator's discretion depending on the complexity of the lesion and procedure.Baseline characteristics, clinical presentation, EuroSCORE (l) [15,16] and angiographic data were recorded.Endpoints of the study include: 1) data captured for safety and feasibility of the technique; 2) 1-year target lesion revascularization (TLR); 3) overall major adverse cardiac events (MACE) at one year defined as cardiac death, myocardial infarction (MI), stroke or any repeat PCI procedure; 4) short term (6 months) and medium & long term survival (1-& 2-year) data were also recorded.The study concluded by the end of the second year of follow-up.
Eighty-four percent of the patients had multi-vessels disease in addition to the severe LMCA.With regard to LMCA lesions, 26 (68%) had ostial disease, 1 (3%) with mid-shaft lesion, 3 (8%) with distal narrowing and 8 (21%) with diffuse disease affecting the LM stem.DES was placed in all cases as the first stent with their mean size of 3.55 ± 0.28mm & length of 15.5 ± 6.2mm.Regarding the second stent onto the same target lesion, 34 (89%) patients had bare metal stent as the second stent with mean size of 4.15 ± 0.43mm & length of 11.8 ± 3.7mm.The second stents were very often larger than the initially deployed stent in 92% of the cases, with 21 stents (55%) larger by 0.5mm, 10 (26%) larger by 1mm & 4 (11%) by >1.5mm (Table 3).All stents were placed successfully.No patient received bifurcation stenting for distal LMCA disease.
There was no in-hospital death.Scanning the robust EMR system, there was neither reported acute stent thrombus (AT) nor subacute stent thrombosis (SAT).Surveillance angiography was performed in 34% of the cases.At one year, for those who survived, no patient required repeat PCI to LM lesion and non-TLR rate was 16%.There was one patient who required open heart surgery for resection of aortic valve fibroelastoma and CABG.Six months survival was 92%, 1-year survival was 87% & 82% by the end of second year.Cumulative one-year MACE (any death, MI, stroke, any repeat PCI) occurred in 10 patients (26%), mainly contributed by non-TLR 6 (16%) & two non-cardiac death.There was no other report on patient with stroke or MI by the end of one year.Nevertheless, there were 7 patients that had passed away by the end of the study in which there were four cardiovascular deaths, one patient suffered from periprocedural stroke & died in skilled nursing facility a month later.One patient died suddenly 10 months post-PCI.One died from cerebral hemorrhage after receiving thrombolytic therapy for acute inferior STEMI in outside facility.One died in hospice from end-stage heart failure.There were 3 other deaths, 1 patient died of terminal lung cancer, one from abdominal sepsis and the last one died from C Diff. colitis (Table 4).

Discussion
After initial stent placement in the LMCA, there exist the occasional suboptimal result due to plaque prolapse, undersize stent use and elastic recoil after bare metal stenting, which necessitate alternate treatment, one of which is the application of double-stenting technique [12,13].The present study is by far the largest reported cohort of patients receiving double-stenting (stent sandwich) of the LMCA.Overlapping stents were deployed successfully in all 38 Use of DES in the LMCA has the unique advantage in the reduction of instent restenosis in comparison to BMS [17,18], however, the former came with a limited size when it was first marketed in early 2000s, and available sizes were often smaller than the diameter of LM stem.This undersizing certainly contributed to suboptimal angiographic result after initial stenting to LMCA.On the other hand, BMS are often available in larger size and can alleviate the problem of undersizing.This was exemplified in our current study in which the DES used for initial deployment was smaller than the second stent (mostly BMS) placed (mean size 3.55 ± 0.28mm versus 4.25 ± 0.43mm).Nevertheless, with the new bigger size DES available in the market, the problem of undersize may resolve, but double-stenting might still be required to handle the problem of elastic recoil and plaque prolapsed.
The use of 'stent sandwich' raised another concern of having excessive metal in close proximity to each other, leading to higher incidence of ST/SAT and/or high rate of restenosis.However, in the present series, there was no patient suffering from ST/SAT and no patient required repeat PCI to LMCA in one year.This again demonstrated that the double-stenting technique is safe and able to provide lasting result.The reasons for these favorable outcomes might related to, firstly, a relatively large luminal diameter of the second stent used (4.25 ± 0.43mm), frequently with high pressure post-dilatation performed, achieving a relatively large final lumen diameter, a 'bigger the better' scenario.Secondly, the actual length of the overlapping stented segment required to achieve good angiographic result was shorter, as shown by the length of the 2 nd stent used was shorter than the first stent (11.8 ± 3.7mm versus 15.5 ± 6.2mm); basically the function of the 2 nd stent was used to target a focal problem like the elastic recoil at the ostium of the LMCA (68% in the present cohort) or focal area of plaque prolapsed.
As mentioned at the beginning, the current study is the largest cohort of patients receiving 'stent sandwich', comparing to other short reports or smaller series, we were able to show the safety & feasibility of the technique in the LMCA, as well as showing the medium & long term results [11][12][13][14].Again, there is no patient requiring TLR.Obviously with a cohort of patients with high percentage of multivessels disease (84%) in addition to LMCA stenosis, the non-TLR rate of 16% was not too unexpected.
There are several limitations on the present study.Firstly, it is a retrospective, nonrandomized analysis of a small cohort of patients.However, the robust EMR system in the Kaiser system allows very accurate data capturing.Information like clinical presentation, angiographic data and follow-up events could be retrieved adequately.In addition, no patient was lost to follow-up in the current series.Secondly, we did not include a control group with single stent placement in LMCA for comparison; certainly, there has been plentiful outcome data of PCI to LMCA in the literature [1][2][3][4][5][6].Thirdly, surveillance angiogram was only performed in 34% of the patients, all of them showed widely patent stents, and again no patient required repeat PCI to LMCA after surveillance angiography or on clinical follow-up.One can argue that without routine surveillance angiogram, the actual incidence of instent restenosis or other local angiographic complication in the LMCA like aneurysmal dilatation could not be accurately documented [19].However, the absence of the need for repeat PCI in the LMCA, in which 74% was unprotected LMCA stenting, argued against significant angiographic restenosis or local complication necessitate further intervention.Besides, we have stopped performing surveillance angiography for patients receiving LMCA stenting as the former is no longer recommended.
In conclusion, favorable outcomes were seen in this unselected cohort of high risk patients undergoing double-stenting of LMCA.The technique is thought to be safe and feasible, provides another option for treatment of severe LMCA disease with suboptimal initial stenting result.

Table 1 :
Indications for placement of double stents: in decreasing order

Table 2 :
Demographics and clinical characteristics

Table 3 :
Angiographic, lesions and stents characteristics BMS: Bare-Metal Stent, DES: Drug-Eluting Stent, mm: Millimeter patients in the study.There was no in-hospital death.There was no reported case of AT/SAT as well.The technique is believed to be safe and feasible procedure for the treatment of suboptimal angiographic result after initial stenting to LMCA disease.Despite being a high risk cohort of patients with high EuroSCORE(l) (mean; logistic 17.7, additive 8.2), these patients who received the double-stenting turned out to have quite favorable procedure outcome.No patient required repeat PCI to LMCA in one year.Short-term (6 months) survival was 92%.Medium & long term survival at 1-year & 2-year were 87% and 82% respectively.

Table 4 :
Outcomes on follow-up One patient requires CABG and resection of aortic valve fibroelastoma CVS deaths: One patient suffered from periprocedural stroke & died in skilled nursing facility a month later.One died suddenly 10 months post-PCI.One died from cerebral hemorrhage after receiving thrombolytic therapy for acute inferior STEMI in outside facility.One died in hospice from end-stage heart failure.Other deaths: one patient died of terminal lung cancer, one died from abdominal sepsis and one died from C Diff colitis.AT: Acute Stent Thrombus; SAT: Subacute Stent Thrombus; TLR: Target Lesion Revascularization, MACE: Major Adverse Cardiac Event, MI: Myocardial Infarction, PCI: Percutaneous Coronary Intervention *